India to Poland Pharmaceutical Export
Bilateral Trade Intelligence · $163.2M Total Trade · 203 Exporters · 418 Buyers · DGFT Verified · Updated March 2026
India exported $163.2M worth of pharmaceutical formulations to Poland across 11,918 verified shipments, sourced from 203 Indian exporters supplying 418 Poland buyers. The top exporters are MACLEODS PHARMACEUTICALS LTD ($34.0M) and INTAS PHARMACEUTICALS LIMITED ($22.4M). The leading products are Etanercept ($10.6M). Average shipment value: $13.7K.
Top Pharmaceutical Formulations — India to Poland
| # | Formulation | Value | Share |
|---|---|---|---|
| 1 | Etanercept Ai 50mg/ml Prespack 11 K | $10.6M | 6.5% |
| 2 | 100% Cotton Bleached Swabs 45x45 17th 4l | $7.5M | 4.6% |
| 3 | Sapropterin Dihydrochloride Tablets 100m | $4.2M | 2.6% |
| 4 | Drugs and Pharmaceuticals Harmless Medicines Mucitus | $4.0M | 2.4% |
| 5 | Rapimax Forte Tablet No.10 (batch.no.226 | $2.8M | 1.7% |
| 6 | Pharmaceutical Products (finished Products ) (generic Name) Viropil 50/300/300m… | $2.8M | 1.7% |
| 7 | Rapimax Tablet No.10 (batch.no.2262001/m | $2.7M | 1.6% |
| 8 | Averelix 75 MG X 28 Tabl (clopidogrel Film Coated Tablets 75 MG Bno:bce2315a Mf… | $1.8M | 1.1% |
| 9 | Averelix 75 MG X 28 Tabl Bno:bce2314a Mfg.dt.sep-2023 Exp.dt.aug-2026 Ps: 4x7s | $1.8M | 1.1% |
| 10 | Averelix 75 MG X 28 Tabl Bno:bce2313a Mfg.dt. Sep-2023 Exp. Dt.aug-2026 Ps: 4x7s | $1.8M | 1.1% |
| 11 | 100% Cotton Bleached Swabs Matocomp 17th | $1.7M | 1.0% |
| 12 | Etanercept Ai 50mg/ml Prespack 11k | $1.5M | 0.9% |
| 13 | Exorta 10 MG X 28 Tabl Bno:bra92312a/bra92314a/13a Mfg.dt. 10/23 Exp. Dt.09/26… | $1.4M | 0.8% |
| 14 | Pharma Drugs & Medi Pelgraz 6mg/0.6ml 1pfs(pl/ro/si)ima_n As Per Invoice | $1.4M | 0.8% |
| 15 | Exorta 10 MG X 28 Tabl Bno:bra92316a Mfg.dt. Oct-2023 Exp.dt. Sep-2026 Ps: 4x7s | $1.2M | 0.8% |
India exports 20+ pharmaceutical formulations to Poland with a combined trade value of $163.2M. Key products include Etanercept ($10.6M). These are finished dosage forms — tablets, capsules, injectables, and combination drugs — shipped from Indian manufacturing facilities with FDA, WHO-GMP, and EU GMP certifications. Data from 11,918 verified Indian Customs (DGFT) shipment records.
Top Pharmaceutical Products — India to Poland Trade Routes
These are the top pharmaceutical products exported from India to Poland, each with a dedicated trade route analysis page. Click any product to see detailed export data including Indian suppliers, Poland buyers, regulatory requirements, and logistics for that specific product corridor. Products include Etanercept ($10.6M) — all finished pharmaceutical formulations verified from Indian Customs (DGFT) records.
Top Indian Exporters to Poland
203 Indian pharmaceutical companies export finished formulations to Poland. Leading exporters include Macleods Pharmaceuticals Ltd, Intas Pharmaceuticals Limited, Watson Pharma Private Limited, Lupin Limited. The top exporter accounts for 20.8% of total India–Poland pharma exports. Source: Indian Customs (DGFT).
Top Poland Buyers from India
418 companies in Poland import pharmaceutical formulations from India. Top buyers include Synoptis Industrial Sp .zo.o, Teva Operations Poland Sp Z.o.o., Torunskie Zaklady Materialow Opatur, Prespack Sp Z.o.o. The largest buyer accounts for 10.8% of India–Poland pharma imports. Source: Indian Customs (DGFT).
Port Analysis — India to Poland Pharmaceutical Shipments
Indian Export Ports
Poland Import Ports
Trade Statistics
Other Destinations
Product Routes
FAQ — India to Poland Pharmaceutical Trade
What is the total value of India's pharmaceutical export to Poland?
India exported pharmaceuticals worth $163.2M to Poland across 11,918 verified shipments.
Who are the top Indian pharmaceutical exporters to Poland?
1. MACLEODS PHARMACEUTICALS LTD — $34.0M. 2. INTAS PHARMACEUTICALS LIMITED — $22.4M. 3. WATSON PHARMA PRIVATE LIMITED — $15.6M. Total: 203 suppliers.
Which companies in Poland import pharmaceuticals from India?
1. SYNOPTIS INDUSTRIAL SP .ZO.O — $17.6M. 2. TEVA OPERATIONS POLAND SP Z.O.O. — $14.2M. 3. TORUNSKIE ZAKLADY MATERIALOW OPATUR — $11.2M. 418 buyers total.
What pharmaceutical products does India export most to Poland?
1. Etanercept Ai 50mg/ml Prespack 11 K ($10.6M, 6.5%); 2. 100% Cotton Bleached Swabs 45x45 17th 4l ($7.5M, 4.6%); 3. Sapropterin Dihydrochloride Tablets 100m ($4.2M, 2.6%); 4. Drugs and Pharmaceuticals Harmless Medicines Mucitus ($4.0M, 2.4%); 5. Rapimax Forte Tablet No.10 (batch.no.226 ($2.8M, 1.7%)
Which ports handle pharmaceutical shipments from India to Poland?
Export: SAHAR AIR CARGO ACC (INBOM4), SAHAR AIR, TUTICORIN ICD, NHAVA SHEVA SEA (INNSA1), MUNDRA SEA. Import: WARSAW, Gdynia, POZNAN, Gdansk, GDYNIA.
Why does Poland import pharmaceuticals from India?
India's cost-competitive generic drug manufacturing, WHO-GMP certified facilities, and broad product portfolio. This $163.2M corridor reflects quality compliance and pricing advantages.
What certifications do Indian pharmaceutical exporters need to supply Poland?
WHO-GMP certification, EU GMP approval (for EU markets), product dossier registration (CTD format), and ICH guideline compliance.
What is the average shipment value for India to Poland pharmaceutical trade?
$13.7K per consignment across 11,918 shipments.
How many Indian pharmaceutical companies export to Poland?
203 Indian companies. Largest: MACLEODS PHARMACEUTICALS LTD with $34.0M.
How can I find verified Indian pharmaceutical suppliers for Poland?
TransData Nexus covers 203 active exporters with shipment history and trade values at transdatanexus.com.
Unlock the Full India to Poland Pharmaceutical Export Dataset
Access complete shipment records, supplier intelligence, buyer histories, and price analytics for all 11,918 shipments.
Official References & Regulatory Resources
- WHO Essential Medicines List
- CDSCO India
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- Pharmexcil
Data sourced from Indian Customs (DGFT) records. Verify regulatory status with the agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Data Source: Indian Customs (DGFT) export shipping bill records covering all pharmaceutical shipments from India.
- 2.Country Matching: Shipments to Poland identified using destination country codes from customs declarations.
- 3.Statistical Normalization: Values are statistically normalized to remove outlier transactions and ensure accurate market share representation.
- 4.Coverage: 11,918 verified shipments from 203 Indian exporters to 418 Poland buyers.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
203 Exporters
418 buyers tracked
Expert-Reviewed
By pharmaceutical trade specialists